1	G.D.	NNP	2	nn
2	Searle	NNP	5	nsubj
3	&	CC	2	cc
4	Co.	NNP	2	conj
5	said	VBD	0	root
6	the	DT	10	det
7	Food	NNP	10	nn
8	and	CC	7	cc
9	Drug	NNP	7	conj
10	Administration	NNP	11	nsubj
11	approved	VBD	5	ccomp
12	the	DT	13	det
13	sale	NN	11	dobj
14	of	IN	13	prep
15	Kerlone	NNP	14	pobj
16	,	,	15	punct
17	a	DT	19	det
18	hypertension	NN	19	nn
19	drug	NN	15	appos
20	developed	VBN	19	partmod
21	by	IN	20	prep
22	a	DT	24	det
23	joint	JJ	24	amod
24	venture	NN	21	pobj
25	between	IN	24	prep
26	Searle	NNP	25	pobj
27	and	CC	26	cc
28	a	DT	30	det
29	French	JJ	30	amod
30	concern	NN	26	conj
31	.	.	5	punct

1	Searle	NNP	9	nsubj
2	,	,	1	punct
3	a	DT	4	det
4	unit	NN	1	appos
5	of	IN	4	prep
6	Monsanto	NNP	7	nn
7	Co.	NNP	5	pobj
8	,	,	1	punct
9	said	VBD	0	root
10	the	DT	15	det
11	``	``	12	punct
12	beta-blocker	NN	15	nn
13	''	''	12	punct
14	high-blood-pressure	JJ	15	amod
15	drug	NN	16	nn
16	Kerlone	NNP	20	nsubj
17	is	VBZ	20	cop
18	the	DT	20	det
19	first	JJ	20	amod
20	product	NN	9	ccomp
21	to	TO	22	aux
22	reach	VB	20	infmod
23	the	DT	24	det
24	market	NN	22	dobj
25	through	IN	22	prep
26	Lorex	NNP	27	nn
27	Pharmaceuticals	NNP	25	pobj
28	,	,	27	punct
29	the	DT	31	det
30	U.S.	NNP	31	nn
31	company	NN	27	appos
32	jointly	RB	33	advmod
33	owned	VBN	31	partmod
34	by	IN	33	prep
35	Searle	NNP	34	pobj
36	and	CC	35	cc
37	Synthelabo	NNP	35	conj
38	,	,	37	punct
39	a	DT	42	det
40	French	JJ	42	amod
41	pharmaceutical	JJ	42	amod
42	concern	NN	37	appos
43	owned	VBN	42	partmod
44	by	IN	43	prep
45	France	NNP	48	poss
46	's	POS	45	possessive
47	L'Oreal	NNP	48	nn
48	S.A	NNP	44	pobj
49	.	.	9	punct


